Joy John Mammen

Joy John Mammen

Auto-generated profile, based on publicly available information

Joy John Mammen

Christian Medical College

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
JPJohn Victor Peter
John Victor Peter
KMK. Prasad Mathews
K. Prasad Mathews
HPHema Paul
Hema Paul
JMJoy J. Mammen
Joy J. Mammen
MMMalathi Murugesan
Malathi Murugesan

6 April 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JMJoy John Mammen
Joy John Mammen
EAEdwin Sam Asirvatham
Edwin Sam Asirvatham
JLJeyaseelan Lakshmanan
Jeyaseelan Lakshmanan
CSCharishma Jones Sarman
Charishma Jones Sarman
APArvind Pandey
Arvind Pandey
SRShobini Rajan
Shobini Rajan
Background: Estimating the clinical demand for blood and components arising in a health facility is crucial to ensure timely availability of blood. This study aims to estimate disease-specific clinical demand, supply and utilization of whole blood and components in India. Methods: We conducted a national level cross-sectional study in five randomly selected states from five regions of the country. We included 251 public and private facilities representing primary, secondary and tertiary care facilities. We collected annual disease-specific demand, supply and utilization of blood and components using a structured tool. We estimated the national demand by extrapolating the study data (demand and beds) to the total number of estimated beds in the country. Findings: According to the study, the total clinical demand of 251 health facilities with 51,562 beds was 474,627 whole blood units. Based on this, the clinical demand for India was estimated at 14·6 million whole blood units (95 CI: 14·59–14·62), an equivalent of 36·3 donations per 1,000 eligible populations, which will address whole blood and component requirement. The medicine specialty accounted for 6·0 million units (41·2%), followed by surgery 4·1 million (27·9%), obstetrics and gynecology 3·3 million (22·4%) and pediatrics 1·2 million (8·5%) units. The supply was 93% which is equivalent to 33·8 donations against the demand. Conclusion: The study indicated a demand and supply gap of 2.5 donations per 1,000 eligible persons which is around one million units. The gap emphasises the need for sustained and concerted efforts from all stakeholders and for increasing the awareness about repeat voluntary non-remunerated blood donation (VNRBD); optimizing the availability of blood components through efficient blood component separation units; promoting modern principles of patient blood management and strengthening capacities of human resources in the blood transfusion system in India.

3 October 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
JMJoy John Mammen
Joy John Mammen
SKSnehil Kumar
Snehil Kumar
LTLovely Thomas
Lovely Thomas
GKGunjan Kumar
Gunjan Kumar
AZAnand Zachariah
Anand Zachariah
VKV Saravana Kumar
V Saravana Kumar
Objective: Large data on the clinical characteristics and outcome of COVID-19 in the Indian population are scarce. We analysed the factors associated with mortality in a cohort of moderately and severely ill patients with COVID-19 enrolled in a randomised trial on convalescent plasma. Design: Secondary analysis of data from a Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications in Moderate Disease. Setting: 39 public and private hospitals across India during the study period from 22 April to 14 July 2020. Participants: Of the 464 patients recruited, two were lost to follow-up, nine withdrew consent and two patients did not receive the intervention after randomisation. The cohort of 451 participants with known outcome at 28 days was analysed. Primary outcome measure: Factors associated with all-cause mortality at 28 days after enrolment. Results: The mean (SD) age was 51±12.4 years; 76.7% were males. Admission Sequential Organ Failure Assessment score was 2.4±1.1. Non-invasive ventilation, invasive ventilation and vasopressor therapy were required in 98.9%, 8.4% and 4.0%, respectively. The 28-day mortality was 14.4%. Median time from symptom onset to hospital admission was similar in survivors (4 days; IQR 3–7) and non-survivors (4 days; IQR 3–6). Patients with two or more comorbidities had 2.25 (95% CI 1.18 to 4.29, p=0.014) times risk of death. When compared with survivors, admission interleukin-6 levels were higher (p<0.001) in non-survivors and increased further on day 3. On multivariable Fine and Gray model, severity of illness (subdistribution HR 1.22, 95% CI 1.11 to 1.35, p<0.001), PaO2/FiO2 ratio 10 (9.97, 3.65–27.13, p1.0 mg/L (2.50, 1.14–5.48, p=0.022), ferritin ≥500 ng/mL (2.67, 1.44–4.96, p=0.002) and lactate dehydrogenase ≥450 IU/L (2.96, 1.60–5.45, p=0.001) were significantly associated with death. Conclusion: In this cohort of moderately and severely ill patients with COVID-19, severity of illness, underlying comorbidities and elevated levels of inflammatory markers were significantly associated with death. Trial registration number: CTRI/2020/04/024775.

15 May 2021 in Transfusion
Verified
Journal Article
Closed access
PDF file
JMJoy John Mammen
Joy John Mammen
EAEdwin Sam Asirvatham
Edwin Sam Asirvatham
JLJeyaseelan Lakshmanan
Jeyaseelan Lakshmanan
CSCharishma Jones Sarman
Charishma Jones Sarman
TMThenmozhi Mani
Thenmozhi Mani
SRShobini Rajan
Shobini Rajan

13 December 2016 in Journal of Intensive Care Medicine
Verified
Journal Article
Open access
JMJoy Mammen
Joy Mammen
JCJui Choudhuri
Jui Choudhuri
JPJoshua Paul
Joshua Paul
TSThomas Isaiah Sudarsan
Thomas Isaiah Sudarsan
TJT. Josephine
T. Josephine
JPJohn Victor Peter
John Victor Peter
The diagnosis of sepsis is challenging in the absence of a gold standard test. Recent studies have explored the role of neutrophil and monocyte volume, conductivity, and scatter (VCS), derived from automated hematology analyzers, in diagnosing sepsis. We assessed the diagnostic accuracy of VCS parameters in critically ill patients with sepsis. In this prospective study, VCS parameters, procalcitonin, and C-reactive protein (CRP) were assessed in patients with proven sepsis (cases) and 2 control groups (intensive care unit [ICU] patients without sepsis and healthy blood donors). The diagnostic property of each test was explored by calculating sensitivity, specificity, negative and positive predictive values, and area under the curve (AUC). The study included 65 patients with sepsis, 58 nonseptic ICU controls, and 98 blood donors. Procalcitonin and CRP were not significantly different (P > .06) between patients with sepsis and nonseptic patients. Mean (95% confidence interval [CI]) neutrophil volume (MNV) was significantly higher (P < .001) in patients with sepsis (165.5; 95%CI 161.6-169.4) than in nonseptic (157.3; 95%CI 154.6-160.1) patients and donors (148.9; 95%CI 147.9-150). A similar pattern was seen with mean monocyte volume (MMoV). Neutrophil and monocyte conductivity and scatter parameters were variably associated. The AUC was highest for MMoV (0.74) and lowest for CRP (0.62). Among all parameters, MNV and MMoV had the highest specificity of 85% and 80%, respectively. In critically ill patients with suspected sepsis, VCS parameters may help strengthen the diagnostic probability of sepsis. Future studies may explore the role of serial monitoring of VCS to track response to antimicrobial therapy.

24 January 2021 in Indian Journal of Hematology and Blood Transfusion
Verified
Journal Article
Closed access
PDF file
EAEdwin Sam Asirvatham
Edwin Sam Asirvatham
JMJoy John Mammen
Joy John Mammen
JLJeyaseelan Lakshman
Jeyaseelan Lakshman
CSCharishma Jones Sarman
Charishma Jones Sarman
BCBimal Charles
Bimal Charles
SRShobini Rajan
Shobini Rajan